{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T08:26:43Z","timestamp":1794212803115,"version":"4.8.0"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.psychres.2026.117036","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:13:27Z","timestamp":1771460007000},"page":"117036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The use of repetitive transcranial magnetic stimulation (rTMS), electroconvulsive therapy (ECT), ketamine, and esketamine in reducing suicidality in major depressive disorder: A comprehensive narrative review"],"prefix":"10.1016","volume":"359","author":[{"given":"Trisha","family":"Menon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4475-2658","authenticated-orcid":false,"given":"Andy","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4146-9635","authenticated-orcid":false,"given":"Akhilan","family":"Arulmozhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine E.","family":"Dri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0928-3433","authenticated-orcid":false,"given":"Sabrina","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla M.","family":"Teopiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6457-0086","authenticated-orcid":false,"given":"Gia Han","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serene","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5087-8263","authenticated-orcid":false,"given":"Cory R.","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4733-2523","authenticated-orcid":false,"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2026.117036_bib0001","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jad.2023.01.005","article-title":"Antidepressant and anti-suicidal effects of ketamine in treatment-resistant depression associated with psychiatric and personality comorbidities: A double-blind randomized trial","volume":"325","author":"Ahmed","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2026.117036_bib0002","series-title":"Comparing Electroconvulsive Therapy and Ketamine in Treating Acute Suicidal Depression [Ongoing Study]","author":"Anand","year":"2022"},{"issue":"2","key":"10.1016\/j.psychres.2026.117036_bib0003","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.rcp.2022.03.001","article-title":"Successful treatment for serious depression with suicidal risk in a heart transplant patient","volume":"53","author":"Arango-Posada","year":"2024","journal-title":"Rev. Colomb. Psiquiatr."},{"issue":"5","key":"10.1016\/j.psychres.2026.117036_bib0004","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/YIC.0000000000000482","article-title":"Long-term remission following esketamine nasal spray sessions in a patient with severe and highly treatment-resistant depression: A single-case report","volume":"39","author":"Arrighi","year":"2023","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2026.117036_bib0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2022.01.104","article-title":"mTORC1 inhibitor effects on rapid ketamine-induced reductions in suicidal ideation in patients with treatment-resistant depression","volume":"303","author":"Averill","year":"2022","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.psychres.2026.117036_bib0006","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41398-019-0377-x","article-title":"Placebo aiTBS attenuates suicidal ideation and frontopolar cortical perfusion in major depression","volume":"9","author":"Baeken","year":"2019","journal-title":"Transl. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2026.117036_bib0007","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/ner.13376","article-title":"Multimodal elements of suicidality reduction after transcranial magnetic stimulation","volume":"24","author":"Barredo","year":"2021","journal-title":"Neuromodulation."},{"issue":"1","key":"10.1016\/j.psychres.2026.117036_bib0008","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1186\/s12888-020-02925-1","article-title":"Predicting therapeutic response to oral ketamine for chronic suicidal ideation: A Bayesian network for clinical decision support","volume":"20","author":"Beaudequin","year":"2020","journal-title":"BMC. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117036_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.114212","article-title":"Relationships between reduction in symptoms and restoration of function and wellbeing: outcomes of the oral ketamine trial on suicidality (OKTOS)","volume":"305","author":"Beaudequin","year":"2021","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2026.117036_bib0010","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jad.2018.04.016","article-title":"Treatment-resistant depression and suicidality","volume":"235","author":"Bergfeld","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2026.117036_bib0011","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jpsychires.2020.03.016","article-title":"Transcranial magnetic stimulation to reduce suicidality\u2014A review and naturalistic outcomes","volume":"125","author":"Bozzay","year":"2020","journal-title":"J. Psychiatr. Res."},{"issue":"18","key":"10.1016\/j.psychres.2026.117036_bib0012","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2217\/cer-2022-0149","article-title":"Safety and effectiveness of intranasal esketamine for treatment-resistant depression: A real-world retrospective study","volume":"11","author":"Brendle","year":"2022","journal-title":"J. Comp. Eff. Res."},{"issue":"10","key":"10.1016\/j.psychres.2026.117036_bib0013","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.7205\/MILMED-D-15-00431","article-title":"A double-blinded, randomized, placebo-controlled sub-dissociative dose ketamine pilot study in the treatment of acute depression and suicidality in a military emergency department setting","volume":"181","author":"Burger","year":"2016","journal-title":"Mil. Med."},{"key":"10.1016\/j.psychres.2026.117036_bib0014","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jad.2021.05.115","article-title":"Prevalence of suicidal ideation and planning in patients with major depressive disorder: A meta-analysis of observation studies","volume":"293","author":"Cai","year":"2021","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.psychres.2026.117036_bib0015","doi-asserted-by":"crossref","first-page":"196","DOI":"10.5152\/npa.2016.14845","article-title":"Electroconvulsive therapy in the treatment of mood disorders: one-year follow-up","volume":"54","author":"\u00c7akir","year":"2017","journal-title":"Noro Psikiyatr. Ars."},{"key":"10.1016\/j.psychres.2026.117036_bib0016","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jad.2024.04.039","article-title":"Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: A systematic review and meta-analysis","volume":"356","author":"Calder","year":"2024","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.psychres.2026.117036_bib0017","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/JCP.0000000000001465","article-title":"Esketamine nasal spray for the rapid reduction of depressive symptoms in major depressive disorder with acute suicidal ideation or behavior","volume":"41","author":"Canuso","year":"2021","journal-title":"J. Clin. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.psychres.2026.117036_bib0018","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1176\/appi.ajp.2018.17060720","article-title":"Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: results of a double-blind, randomized, placebo-controlled study","volume":"175","author":"Canuso","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117036_bib0019","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jad.2018.08.082","article-title":"What is the relationship between rejection and self-harm or suicidality in adulthood?","volume":"242","author":"Cawley","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"9","key":"10.1016\/j.psychres.2026.117036_bib0020","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s40263-021-00846-5","article-title":"Prevention and management of common adverse effects of ketamine and esketamine in patients with mood disorders","volume":"35","author":"Ceban","year":"2021","journal-title":"CNS. Drugs"},{"issue":"1","key":"10.1016\/j.psychres.2026.117036_bib0021","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/ipj.ipj_231_21","article-title":"Retrospective data analysis to determine the effectiveness of intravenous ketamine therapy on patients suffering from depression with suicidal ideation","volume":"32","author":"Chaudhary","year":"2023","journal-title":"Ind. Psychiatry J."},{"key":"10.1016\/j.psychres.2026.117036_bib0022","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jad.2023.08.061","article-title":"Role of klotho on antidepressant and antisuicidal effects of low-dose ketamine infusion among patients with treatment-resistant depression and suicidal ideation","volume":"340","author":"Chen","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2026.117036_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114749","article-title":"Comparative study of low-dose ketamine infusion and repetitive transcranial magnetic stimulation in treatment-resistant depression: A posthoc pooled analysis of two randomized, double-blind, placebo-controlled studies","volume":"316","author":"Chen","year":"2022","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2026.117036_bib0024","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jad.2019.03.075","article-title":"Antisuicidal effect, BDNF Val66Met polymorphism, and low-dose ketamine infusion: reanalysis of adjunctive ketamine study of Taiwanese patients with treatment-resistant depression (AKSTP-TRD)","volume":"251","author":"Chen","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.psychres.2026.117036_bib0025","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00406-023-01735-2","article-title":"Effects of melancholic features on positive and negative suicidal ideation in patients with treatment-resistant depression and strong suicidal ideation receiving low-dose ketamine infusion","volume":"274","author":"Chen","year":"2024","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.psychres.2026.117036_bib0026","doi-asserted-by":"crossref","first-page":"e2820","DOI":"10.1002\/hup.2820","article-title":"Low-dose ketamine infusion in treatment-resistant double depression: revisiting the adjunctive ketamine study of Taiwanese patients with treatment-resistant depression","author":"Chen","year":"2022","journal-title":"Hum. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2026.117036_bib0027","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/YCT.0000000000000636","article-title":"Effects of low-dose ketamine on the antidepressant efficacy and suicidal ideations in patients undergoing electroconvulsive therapy","volume":"36","author":"Chen","year":"2020","journal-title":"J. ECT."},{"key":"10.1016\/j.psychres.2026.117036_bib0028","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jad.2025.04.119","article-title":"The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review","volume":"382","author":"Cheng","year":"2025","journal-title":"J. Affect. Disord."},{"issue":"8","key":"10.1016\/j.psychres.2026.117036_bib0029","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1176\/appi.ajp.2019.19070720","article-title":"Stanford accelerated intelligent neuromodulation therapy for treatment-resistant depression","volume":"177","author":"Cole","year":"2020","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117036_bib0030","unstructured":"Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia. Available at www.covidence.org."},{"key":"10.1016\/j.psychres.2026.117036_bib0031","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jad.2023.12.038","article-title":"The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data","volume":"348","author":"d\u2019Andrea","year":"2024","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.psychres.2026.117036_bib0032","first-page":"7947","article-title":"Repetitive transcranial magnetic stimulation (rTMS) using different TMS instruments for major depressive disorder at a suburban tertiary clinic","volume":"11","author":"Davila","year":"2019","journal-title":"Ment. Illn."},{"key":"10.1016\/j.psychres.2026.117036_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110507","article-title":"Electrophysiological correlates and predictors of the antidepressant response to repeated ketamine infusions in treatment-resistant depression","volume":"115","author":"de la Salle","year":"2022","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.psychres.2026.117036_bib0034","first-page":"48","article-title":"The acute effects of accelerated repetitive Transcranial Magnetic Stimulation on suicide risk in unipolar depression: preliminary results","volume":"26","author":"Desmyter","year":"2014","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.psychres.2026.117036_bib0035","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3389\/fnhum.2016.00480","article-title":"Accelerated intermittent theta burst stimulation for suicide risk in therapy-resistant depressed patients: A randomized, sham-controlled trial","volume":"10","author":"Desmyter","year":"2016","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.psychres.2026.117036_bib0036","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jpsychires.2021.09.002","article-title":"Ketamine monotherapy versus adjunctive ketamine in adults with treatment-resistant depression: results from the Canadian Rapid Treatment Centre of Excellence","volume":"143","author":"Di Vincenzo","year":"2021","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.psychres.2026.117036_bib0037","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1080\/13811118.2021.1878078","article-title":"Single, fixed-dose intranasal ketamine for alleviation of acute suicidal ideation. An Emergency department, trans-diagnostic approach: A randomized, double-blind, placebo-controlled, proof-of-concept trial","volume":"26","author":"Domany","year":"2022","journal-title":"Arch. Suicide Res."},{"issue":"7","key":"10.1016\/j.psychres.2026.117036_bib0038","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41380-018-0256-5","article-title":"Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)","volume":"25","author":"Fava","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117036_bib0039","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.euroneuro.2021.04.024","article-title":"The effect of single administration of intravenous ketamine augmentation on suicidal ideation in treatment-resistant unipolar depression: results from a randomized double-blind study","volume":"49","author":"Feeney","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.psychres.2026.117036_bib0040","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m13191","article-title":"Esketamine nasal spray for rapid reduction of major depressive disorder symptoms in patients who have active suicidal ideation with intent: double-blind, randomized study (ASPIRE I)","volume":"81","author":"Fu","year":"2020","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2026.117036_bib0041","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1186\/s12888-023-05017-y","article-title":"Esketamine versus placebo on time to remission in major depressive disorder with acute suicidality","volume":"23","author":"Fu","year":"2023","journal-title":"BMC Psych"},{"issue":"4","key":"10.1016\/j.psychres.2026.117036_bib0042","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1440-1819.2005.01395.x","article-title":"Clinical application of single-pulse transcranial magnetic stimulation for the treatment of depression","volume":"59","author":"Fujita","year":"2005","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"101545006","key":"10.1016\/j.psychres.2026.117036_bib0043","article-title":"Case report: repeated series of ketamine infusions in patients with treatment-resistant depression: presentation of five cases","volume":"12","author":"Galuszko-Wegielnik","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2026.117036_bib0044","first-page":"354","article-title":"Magnetoencephalographic correlates of suicidal ideation in major depression","volume":"5","author":"Gilbert","year":"2020","journal-title":"Biol. Psychiatry Cogn. Neurosci. NeuroimAging"},{"issue":"4","key":"10.1016\/j.psychres.2026.117036_bib0045","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1176\/appi.ajp.2017.17060647","article-title":"Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial","volume":"175","author":"Grunebaum","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117036_bib0046","article-title":"Computerized-adaptive vs. Traditional ratings of depression and suicidal thoughts: an assay sensitivity pilot study in a","volume":"12","author":"Grunebaum","year":"2021","journal-title":"Ketamine Clin. Trial. Front Psychiatry"},{"key":"10.1016\/j.psychres.2026.117036_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.115865","article-title":"IV low dose ketamine infusions for treatment resistant depression: results from a five-year study at a free public clinic in an academic hospital","volume":"335","author":"Gutierrez","year":"2024","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2026.117036_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.116125","article-title":"IN Esketamine and IV Ketamine: results of a multi-site observational study assessing the effectiveness and tolerability of two novel therapies for treatment-resistant depression","volume":"340","author":"Gutierrez","year":"2024","journal-title":"Psychiatry Res."},{"issue":"6","key":"10.1016\/j.psychres.2026.117036_bib0049","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11920-008-0075-5","article-title":"Novel targets for antidepressant therapies","volume":"10","author":"Holtzheimer","year":"2008","journal-title":"Curr. Psychiatry Rep."},{"issue":"10","key":"10.1016\/j.psychres.2026.117036_bib0050","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/da.20731","article-title":"Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression","volume":"27","author":"Holtzheimer","year":"2010","journal-title":"Depress. Anxiety."},{"issue":"4","key":"10.1016\/j.psychres.2026.117036_bib0051","doi-asserted-by":"crossref","DOI":"10.1111\/appy.12548","article-title":"Efficacy and safety of esketamine nasal spray in addition to standard of care in patients with major depressive disorder who have active suicidal ideation with intent: A subgroup analysis of the Asian cohort of ASPIRE I","volume":"15","author":"Hong","year":"2023","journal-title":"Asia Pac. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117036_bib0052","first-page":"1","article-title":"Effects of ketamine on individual symptoms and symptom networks of depression in a randomised controlled trial of ketamine for treatment-resistant depression","author":"Hossein","year":"2025","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2026.117036_bib0053","doi-asserted-by":"crossref","DOI":"10.1155\/da\/1767477","article-title":"Therapeutic efficacy of reward circuit-targeted transcranial magnetic stimulation (TMS) on suicidal ideation in depressed patients: A sham-controlled trial of two TMS protocols","author":"Huang","year":"2025","journal-title":"Depress. Anxiety."},{"key":"10.1016\/j.psychres.2026.117036_bib0054","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jad.2018.09.037","article-title":"Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial","volume":"243","author":"Ionescu","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.psychres.2026.117036_bib0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/ijnp\/pyaa068","article-title":"Esketamine nasal spray for rapid reduction of depressive symptoms in patients with major depressive disorder who have active suicide ideation with intent: results of a phase 3, double-blind, randomized study (ASPIRE II)","volume":"24","author":"Ionescu","year":"2021","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.psychres.2026.117036_bib0056","doi-asserted-by":"crossref","first-page":"e719","DOI":"10.4088\/JCP.15m10056","article-title":"Rapid and sustained reductions in current suicidal ideation following repeated doses of intravenous ketamine: secondary analysis of an open-label study","volume":"77","author":"Ionescu","year":"2016","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2026.117036_bib0057","first-page":"152","article-title":"Completed suicide and recent electroconvulsive therapy in Finland","volume":"12","author":"Isomets\u00e4","year":"1996","journal-title":"Convuls. Ther."},{"key":"10.1016\/j.psychres.2026.117036_bib0058","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jpsychires.2021.08.003","article-title":"Suicide prediction among men and women with depression: A population-based study","volume":"142","author":"Jiang","year":"2021","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.psychres.2026.117036_bib0059","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/0269881119895518","article-title":"Electroconvulsive therapy, depression severity and mortality: data from the Danish National Patient Registry","volume":"34","author":"J\u00f8rgensen","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2026.117036_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2023.103678","article-title":"The efficacy of oral ketamine in severely depressed patients at high risk of suicide","volume":"86","author":"Kaur","year":"2023","journal-title":"Asian J. Psychiatr."},{"issue":"1","key":"10.1016\/j.psychres.2026.117036_bib0061","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jad.2012.01.045","article-title":"Suicidal ideation and the subjective aspects of depression","volume":"140","author":"Keilp","year":"2012","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.psychres.2026.117036_bib0062","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.21m13921","article-title":"Effects of Ketamine versus Midazolam on neurocognition at 24 hours in depressed patients with suicidal ideation","volume":"82","author":"Keilp","year":"2021","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2026.117036_bib0063","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1176\/appi.ajp.162.5.977","article-title":"Relief of expressed suicidal intent by ECT: a consortium for research in ECT study","volume":"162","author":"Kellner","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2026.117036_bib0064","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1186\/s12888-021-03616-1","article-title":"Treatment patterns of patients diagnosed with major depressive disorder and suicidal ideation or attempt: a U.S. population-based study utilizing real-world data","volume":"21","author":"Kern","year":"2021","journal-title":"BMC. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2026.117036_bib0065","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/YCT.0b013e318221b31c","article-title":"Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for the treatment of major depressive disorder, a randomized controlled clinical trial","volume":"27","author":"Keshtkar","year":"2011","journal-title":"J. ECT."},{"issue":"6","key":"10.1016\/j.psychres.2026.117036_bib0066","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/JCP.0000000000001289","article-title":"Comparison of rapid antidepressant and antisuicidal effects of intramuscular ketamine, oral Ketamine, and electroconvulsive therapy in patients with major depressive disorder: A pilot study","volume":"40","author":"Kheirabadi","year":"2020","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2026.117036_bib0067","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jad.2023.09.024","article-title":"Non-inferiority of intermittent theta burst stimulation over the left V(1) vs. Classical target for depression: A randomized, double-blind trial","volume":"343","author":"Kong","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.psychres.2026.117036_bib0068","article-title":"A global population-based study on the association between ketamine and esketamine with suicidality using WHO VigiBase","volume":"86","author":"Kwan","year":"2025","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117036_bib0069","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jad.2024.09.118","article-title":"Association between rumination, suicidal ideation and suicide attempts in persons with depressive and other mood disorders and healthy controls: A systematic review and meta-analysis","volume":"368","author":"Le","year":"2025","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.psychres.2026.117036_bib0070","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.brs.2015.05.005","article-title":"Efficacy and safety of low-field synchronized transcranial magnetic stimulation (sTMS) for treatment of major depression","volume":"8","author":"Leuchter","year":"2015","journal-title":"Brain Stimul."},{"issue":"1","key":"10.1016\/j.psychres.2026.117036_bib0071","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40345-015-0032-2","article-title":"The suicide prevention effect of lithium: more than 20 years of evidence\u2014A narrative review","volume":"3","author":"Lewitzka","year":"2015","journal-title":"Int. J. Bipolar. Disord."},{"key":"10.1016\/j.psychres.2026.117036_bib0072","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jad.2024.08.087","article-title":"Fast depressive symptoms improvement in bipolar I disorder after Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT): A two-site feasibility and safety open-label trial","volume":"365","author":"Li","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2026.117036_bib0073","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jad.2023.05.024","article-title":"Right dorsolateral prefrontal cortex volumetric reduction is associated with antidepressant effect of low-dose ketamine infusion: A randomized, double-blind, midazolam-controlled PET-MRI clinical trial","volume":"335","author":"Li","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.psychres.2026.117036_bib0074","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/bdi.12589","article-title":"Superior anti-suicidal effects of electroconvulsive therapy in unipolar disorder and bipolar depression","volume":"20","author":"Liang","year":"2018","journal-title":"Bipolar. Disord."},{"issue":"4","key":"10.1016\/j.psychres.2026.117036_bib0075","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/YCT.0000000000000676","article-title":"Electroconvulsive therapy versus fluoxetine in suicidal resolution for patients with major depressive disorder","volume":"36","author":"Lin","year":"2020","journal-title":"J. ECT."},{"issue":"8","key":"10.1016\/j.psychres.2026.117036_bib0076","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1177\/02698811231182107","article-title":"Baseline cognitive function predicts full remission of suicidal symptoms among patients with treatment-resistant depression and strong suicidal ideation after low-dose ketamine infusion","volume":"37","author":"Lin","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2026.117036_bib0077","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jpsychires.2024.06.020","article-title":"Rapid and long-lasting effects of subcutaneous esketamine on suicidality: an open-label study in patients with treatment-resistant depression","volume":"176","author":"Lopes","year":"2024","journal-title":"J. Psychiatr. Res."},{"issue":"7","key":"10.1016\/j.psychres.2026.117036_bib0078","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1176\/appi.ajp.2020.20060864","article-title":"Improving suicide prevention through evidence-based strategies: A systematic review","volume":"178","author":"Mann","year":"2021","journal-title":"Am. J. Psychiatry"},{"issue":"7906073","key":"10.1016\/j.psychres.2026.117036_bib0079","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jad.2022.09.043","article-title":"Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study)","volume":"319","author":"Martinotti","year":"2022","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.psychres.2026.117036_bib0080","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","article-title":"Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation","volume":"178","author":"McIntyre","year":"2021","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2026.117036_bib0081","first-page":"394","article-title":"Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions","volume":"22","author":"McIntyre","year":"2023","journal-title":"WPA"},{"issue":"11","key":"10.1016\/j.psychres.2026.117036_bib143","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s40263-024-01114-y","article-title":"Glutamatergic modulators for major depression from theory to clinical use","volume":"38","author":"McIntyre","year":"2024","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2026.117036_bib0082","first-page":"1","article-title":"The association between ketamine and esketamine and suicidality: reports to the Food And Drug Administration Adverse Event Reporting System (FAERS)","author":"McIntyre","year":"2024","journal-title":"Expert. Opin. Drug Saf."},{"key":"10.1016\/j.psychres.2026.117036_bib0083","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.euroneuro.2024.05.009","article-title":"Safety and tolerability of esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression","volume":"85","author":"McIntyre","year":"2024","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.psychres.2026.117036_bib0084","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/acps.13412","article-title":"Effect of high frequency versus theta-burst repetitive transcranial magnetic stimulation on suicidality in patients with treatment-resistant depression","volume":"145","author":"Mehta","year":"2022","journal-title":"Acta Psychiatr. Scand."},{"issue":"2","key":"10.1016\/j.psychres.2026.117036_bib0085","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.21r13969","article-title":"The effect of repetitive transcranial magnetic stimulation on suicidal ideation in treatment-resistant depression: A meta-analysis","volume":"83","author":"Mehta","year":"2022","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117036_bib0086","series-title":"Study Quality Assessment Tools","year":"2021"},{"issue":"7","key":"10.1016\/j.psychres.2026.117036_bib0087","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/jamapsychiatry.2022.1074","article-title":"Evaluation of the trajectory of depression severity with ketamine and esketamine treatment in a clinical setting","volume":"79","author":"Nikayin","year":"2022","journal-title":"JAMa Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2026.117036_bib0088","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/14740338.2022.2066651","article-title":"Long-term safety of ketamine and esketamine in treatment of depression","volume":"21","author":"Nikayin","year":"2022","journal-title":"Expert. Opin. Drug Saf."},{"key":"10.1016\/j.psychres.2026.117036_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.112873","article-title":"Suicidal behavior in treatment resistant major depressive disorder patients treated with transmagnetic stimulation (TMS) and its relationship with cognitive functions","volume":"286","author":"Ozcan","year":"2020","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.psychres.2026.117036_bib0090","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41398-024-03033-4","article-title":"Suicidal ideation following ketamine prescription in patients with recurrent major depressive disorder: a nation-wide cohort study","volume":"14","author":"Pan","year":"2024","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117036_bib0091","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jad.2022.11.059","article-title":"Effects of neuronavigation-guided rTMS on serum BDNF, TrkB and VGF levels in depressive patients with suicidal ideation","volume":"323","author":"Pan","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.psychres.2026.117036_bib0092","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/cpt.1858","article-title":"Neuronavigation-guided rTMS for the treatment of depressive patients with suicidal ideation: A double-blind, randomized, sham-controlled trial","volume":"108","author":"Pan","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.psychres.2026.117036_bib0093","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci13101494","article-title":"The patient\u2019s perspective on the effects of intranasal esketamine in treatment-resistant depression","volume":"13","author":"Pepe","year":"2023","journal-title":"Brain Sci."},{"issue":"4","key":"10.1016\/j.psychres.2026.117036_bib0094","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41386-019-0570-x","article-title":"Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression","volume":"45","author":"Phillips","year":"2020","journal-title":"Neuropsychopharmacol"},{"issue":"3","key":"10.1016\/j.psychres.2026.117036_bib0095","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/YIC.0000000000000455","article-title":"Clinical experiences with intranasal esketamine for major depressive disorder resistant to treatment and with a psychiatric emergency: case presentations","volume":"38","author":"Pompili","year":"2023","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2026.117036_bib0096","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/da.22253","article-title":"Effects of ketamine on explicit and implicit suicidal cognition: A randomized controlled trial in treatment-resistant depression","volume":"31","author":"Price","year":"2014","journal-title":"Depress. Anxiety."},{"issue":"5","key":"10.1016\/j.psychres.2026.117036_bib0097","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.biopsych.2009.04.029","article-title":"Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression","volume":"66","author":"Price","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2026.117036_bib0098","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00406-023-01648-0","article-title":"Accelerated sequential bilateral theta-burst stimulation in major depression: an open trial","volume":"274","author":"Ramasubbu","year":"2024","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.psychres.2026.117036_bib0099","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/02698811241238284","article-title":"Brain-derived neurotrophic factor Val66Met and CYP2B6 polymorphisms as predictors for ketamine effectiveness in patients with treatment-resistant depression","volume":"38","author":"Rodrigues","year":"2024","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2026.117036_bib0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/YCT.0000000000000790","article-title":"Self-harm and suicide attempts preceding and following electroconvulsive therapy: A population-based study","volume":"38","author":"Salagre","year":"2022","journal-title":"J. ECT."},{"key":"10.1016\/j.psychres.2026.117036_bib0101","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2025.104413","article-title":"Oral ketamine for rapid reduction of suicidal ideation in major depressive disorder: A midazolam-controlled randomized clinical trial","volume":"106","author":"Seraj","year":"2025","journal-title":"Asian J. Psychiatr."},{"issue":"1","key":"10.1016\/j.psychres.2026.117036_bib0102","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2215-0366(17)30272-9","article-title":"Side-effects associated with ketamine use in depression: a systematic review","volume":"5","author":"Short","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2026.117036_bib0103","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/jama.2024.5756","article-title":"Management of depression in adults: A review","volume":"332","author":"Simon","year":"2024","journal-title":"JAMa"},{"issue":"8","key":"10.1016\/j.psychres.2026.117036_bib0104","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1176\/appi.ajp.2016.16010037","article-title":"A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression","volume":"173","author":"Singh","year":"2016","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2026.117036_bib0105","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.biopsych.2015.10.018","article-title":"Intravenous esketamine in adult treatment-resistant depression: A double-blind, double-randomization, placebo-controlled study","volume":"80","author":"Singh","year":"2016","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.psychres.2026.117036_bib0106","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jad.2018.07.073","article-title":"Ketamine augmentation for major depressive disorder and suicidal ideation: preliminary experience in an inpatient psychiatry setting","volume":"241","author":"Sinyor","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2026.117036_bib0107","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1038\/s41380-024-02478-9","article-title":"Oral esketamine in patients with treatment-resistant depression: A double-blind, randomized, placebo-controlled trial with open-label extension","volume":"29","author":"Smith-Apeldoorn","year":"2024","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2026.117036_bib0108","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.brs.2025.01.005","article-title":"Repetitive transcranial magnetic stimulation for the treatment of suicidal ideation in a naturalistic setting","volume":"18","author":"Stapper","year":"2025","journal-title":"Brain Stim"},{"issue":"5","key":"10.1016\/j.psychres.2026.117036_bib0109","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/ijnp\/pyad014","article-title":"A randomized, double-blind, midazolam-controlled trial of low-dose ketamine infusion in patients with treatment-resistant depression and prominent suicidal ideation","volume":"26","author":"Su","year":"2023","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"10","key":"10.1016\/j.psychres.2026.117036_bib0110","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s40261-022-01193-z","article-title":"Efficacy and safety of subcutaneous esketamine in the treatment of suicidality in major depressive disorder and bipolar depression","volume":"42","author":"Surjan","year":"2022","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.psychres.2026.117036_bib0111","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.768819","article-title":"Clinical response of major depressive disorder patients with suicidal ideation to individual target-transcranial magnetic stimulation","volume":"12","author":"Tang","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2026.117036_bib0112","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/1039856217748249","article-title":"Transcranial magnetic stimulation (TMS) safety: a practical guide for psychiatrists","volume":"26","author":"Taylor","year":"2018","journal-title":"Australas. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117036_bib0113","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jad.2022.10.041","article-title":"Cognitive-affective processes and suicidality in response to repetitive transcranial magnetic stimulation for treatment resistant depression","volume":"321","author":"Terpstra","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.psychres.2026.117036_bib0114","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4103\/0253-7176.101793","article-title":"Rapid response with ketamine on suicidal cognition in resistant depression","volume":"34","author":"Thakurta","year":"2012","journal-title":"Indian J. Psychol. Med."},{"issue":"1","key":"10.1016\/j.psychres.2026.117036_bib0115","first-page":"131","article-title":"Adjunctive intranasal esketamine for comorbid treatment-resistant depression with suicidal ideation in patients receiving palliative care at a Comprehensive Cancer center: A case series","volume":"28","author":"Tomy","year":"2025","journal-title":"J. Palliat. Med."},{"issue":"3","key":"10.1016\/j.psychres.2026.117036_bib0116","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/YCT.0b013e3181efa1b2","article-title":"A review of continuation electroconvulsive therapy: application, safety, and efficacy","volume":"26","author":"Trevino","year":"2010","journal-title":"J. ECT."},{"issue":"1","key":"10.1016\/j.psychres.2026.117036_bib0117","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41380-024-02640-3","article-title":"Thalamocortical functional connectivity and rapid antidepressant and antisuicidal effects of low-dose ketamine infusion among patients with treatment-resistant depression","volume":"30","author":"Tu","year":"2025","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117036_bib0118","first-page":"1","article-title":"Treatment response to esketamine nasal spray in patients with major depressive disorder and acute suicidal ideation or behavior without evidence of early response: A pooled post hoc analysis of ASPIRE","author":"Turkoz","year":"2022","journal-title":"CNS. Spectr."},{"key":"10.1016\/j.psychres.2026.117036_bib0119","unstructured":"U.S. Food and Drug Administration. (2011, July 26). Repetitive transcranial magnetic stimulation (rTMS) systems\u2014Class II special controls guidance for industry and FDA staff. https:\/\/www.fda.gov\/medical-devices\/guidance-documents-medical-devices-and-radiation-emitting-products\/repetitive-transcranial-magnetic-stimulation-rtms-systems-class-ii-special-controls-guidance."},{"key":"10.1016\/j.psychres.2026.117036_bib0120","unstructured":"U.S. Food and Drug Administration. (2018, December 21). FDA Brief: FDA takes action to ensure regulation of electroconvulsive therapy devices better protects patients, reflects current understanding of safety and effectiveness. https:\/\/www.fda.gov\/news-events\/fda-brief\/fda-brief-fda-takes-action-ensure-regulation-electroconvulsive-therapy-devices-better-protects."},{"key":"10.1016\/j.psychres.2026.117036_bib0121","unstructured":"U.S. Food and Drug Administration. (2025, January). SPRAVATO\u00ae (esketamine) nasal spray: highlights of prescribing information [Label]. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/211243s016lbl.pdf."},{"issue":"1198","key":"10.1016\/j.psychres.2026.117036_bib0122","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/postmj\/qgae142","article-title":"An evaluation of the efficacy and side effects of a single dose of ketamine in major depressive disorder","volume":"101","author":"Uyar","year":"2024","journal-title":"Postgr. Med J"},{"issue":"2","key":"10.1016\/j.psychres.2026.117036_bib0123","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/cpt.3478","article-title":"Ketamine and esketamine in clinical trials: FDA-approved and emerging indications, trial trends with putative mechanistic explanations","volume":"117","author":"Vekhova","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.psychres.2026.117036_bib0124","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/JCP.0000000000000960","article-title":"Efficacy and safety of a rapid intravenous injection of ketamine 0.5 mg\/kg in treatment-resistant major depression: an open 4-week longitudinal study","volume":"38","author":"Vidal","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2026.117036_bib0125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.genhosppsych.2020.12.011","article-title":"Ketamine and esketamine augmentation for suicidal ideation: A randomized, double-blinded clinical trial","volume":"68","author":"Vieira","year":"2021","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117036_bib0126","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2022.103189","article-title":"Intensive rTMS for treatment-resistant depression patients with suicidal ideation: an open-label study","volume":"74","author":"Wang","year":"2022","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.psychres.2026.117036_bib0127","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s00406-024-01903-y","article-title":"Predictors of response to accelerated rTMS in the treatment of treatment-resistant depression","volume":"275","author":"Wang","year":"2024","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.psychres.2026.117036_bib0128","first-page":"376","article-title":"A case report of A patient with treatment-resistant depression successfully treated with repeated intravenous injections of A low dosage of ketamine","volume":"29","author":"Wang","year":"2017","journal-title":"Shanghai. Arch. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2026.117036_bib0129","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m11692","article-title":"Bilateral repetitive transcranial magnetic stimulation decreases suicidal ideation in depression","volume":"79","author":"Weissman","year":"2018","journal-title":"J. Clin. Psychiatry"},{"issue":"7","key":"10.1016\/j.psychres.2026.117036_bib0130","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/s41386-020-00953-9","article-title":"Predictors of change in suicidal ideation across treatment phases of major depressive disorder: analysis of the STARD data","volume":"46","author":"Weissman","year":"2021","journal-title":"Neuropsychopharmacol"},{"issue":"6","key":"10.1016\/j.psychres.2026.117036_bib0131","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/acps.13502","article-title":"Suicidality and relief of depressive symptoms with intermittent theta burst stimulation in a sham-controlled randomized clinical trial","volume":"146","author":"Wilkening","year":"2022","journal-title":"Acta Psychiatr. Scand."},{"issue":"9","key":"10.1016\/j.psychres.2026.117036_bib0132","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/jamapsychiatry.2018.1483","article-title":"Effect of repetitive transcranial magnetic stimulation on treatment-resistant major depression in US veterans: A randomized clinical trial","volume":"75","author":"Yesavage","year":"2018","journal-title":"JAMa Psychiatry"},{"issue":"8","key":"10.1016\/j.psychres.2026.117036_bib0133","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41386-023-01577-5","article-title":"Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study","volume":"48","author":"Zaki","year":"2023","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.psychres.2026.117036_bib0134","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s00406-024-01929-2","article-title":"The effect of once-daily vs. twice-daily intermittent theta burst stimulation on suicidal ideation in treatment-resistant depression","volume":"275","author":"Zapf","year":"2024","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psychres.2026.117036_bib0135","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jad.2024.05.109","article-title":"Trajectories of suicidal ideation during rTMS for treatment-resistant depression","volume":"360","author":"Zhan","year":"2024","journal-title":"J. Affect. Disord."},{"issue":"101517820","key":"10.1016\/j.psychres.2026.117036_bib0137","article-title":"Efficacy and safety of repeated esketamine intravenous infusion in the treatment of treatment-resistant depression: A case series","volume":"68","author":"Zhang","year":"2022","journal-title":"Asian J. Psychiatr."},{"issue":"2","key":"10.1016\/j.psychres.2026.117036_bib0138","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/YCT.0000000000000739","article-title":"An open-label trial of adjuvant high-frequency left prefrontal repetitive transcranial magnetic stimulation for treating suicidal ideation in adolescents and adults with depression","volume":"37","author":"Zhang","year":"2021","journal-title":"J. ECT."},{"issue":"1","key":"10.1016\/j.psychres.2026.117036_bib0139","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.biopsych.2023.12.013","article-title":"Comparisons of accelerated continuous and intermittent theta burst stimulation for treatment-resistant depression and suicidal ideation","volume":"96","author":"Zhao","year":"2024","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2026.117036_bib0140","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1177\/0269881119827811","article-title":"Investigation of medical effect of multiple ketamine infusions on patients with major depressive disorder","volume":"33","author":"Zheng","year":"2019","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.psychres.2026.117036_bib0141","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1037\/pha0000437","article-title":"Compounded intranasal racemic ketamine for major depressive disorder: A case report","volume":"29","author":"Ziegler","year":"2021","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2026.117036_bib0142","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12888-024-05716-0","article-title":"Rapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: A randomized clinical trial","volume":"24","author":"Zolghadriha","year":"2024","journal-title":"BMC. Psychiatry"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178126000971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178126000971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T08:13:16Z","timestamp":1794211996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178126000971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":142,"alternative-id":["S0165178126000971"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2026.117036","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of repetitive transcranial magnetic stimulation (rTMS), electroconvulsive therapy (ECT), ketamine, and esketamine in reducing suicidality in major depressive disorder: A comprehensive narrative review","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2026.117036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117036"}}